H.C. Wainwright analyst Emily Bodnar raised the firm’s price target on AnaptysBio (ANAB) to $22 from $19 and keeps a Neutral rating on the ...
H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $81 from $87 and keeps a Buy rating on the shares. Given the company’s ...
Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Viking Therapeutics in a research note issued on Thursday, February 6th. HC Wainwright analyst J. Pantginis expects that ...
D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at ...
2d
Hosted on MSNHC Wainwright & Co. Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, HC Wainwright & Co. downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX ...
H.C. Wainwright analyst Scott Buck revised the price target on Yatra Online (NASDAQ:YTRA) to $3.00 from the previous $4.00, while maintaining a Buy rating on the company's stock. The adjustment ...
Rufus Wainwright is a difficult artist to categorize at the best of times. The Canadian-American musician has recorded pop songs, folk music, operas and stage musicals, but his latest album ...
Rufus Wainwright will perform at Cure Addiction Now’s inaugural fundraising gala in Los Angeles. CAN was founded by Nancy Davis and her late son Jason Davis to support innovative treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results